220 related articles for article (PubMed ID: 23216407)
1. Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological study.
Dika E; Fanti PA; Ismaili A; Misciali C; Vaccari S; Barisani A; Patrizi A
J Dermatolog Treat; 2013 Jun; 24(3):238-42. PubMed ID: 23216407
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer.
Chiller K; Passaro D; McCalmont T; Vin-Christian K
Arch Dermatol; 2000 Nov; 136(11):1327-32. PubMed ID: 11074693
[TBL] [Abstract][Full Text] [Related]
4. Videodermoscopy and Curettage: The Value of Simple Procedures During Mohs Surgery.
Dika E; Fanti PA; Christman H; Ravaioli GM; Patrizi A
Dermatol Surg; 2017 Dec; 43(12):1411-1417. PubMed ID: 28858922
[TBL] [Abstract][Full Text] [Related]
5. Presurgical curettage appropriately reduces the number of Mohs stages by better delineating the subclinical extensions of tumor margins.
Chung VQ; Bernardo L; Jiang SB
Dermatol Surg; 2005 Sep; 31(9 Pt 1):1094-9; discussion 1100. PubMed ID: 16164856
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma.
Lee DA; Ratner D
Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474
[TBL] [Abstract][Full Text] [Related]
8. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
9. Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.
Filho LL; de Oliveira de Avelar Alchorne A; Pereira GC; Lopes LR; de Carvalho TC
Int J Dermatol; 2008 Jun; 47(6):610-4. PubMed ID: 18477158
[TBL] [Abstract][Full Text] [Related]
10. Demographics of basal cell carcinoma and its surgical management.
Afridi RA; Ahmed E; Khan SA; Ali A
J Ayub Med Coll Abbottabad; 2012; 24(3-4):141-3. PubMed ID: 24669636
[TBL] [Abstract][Full Text] [Related]
11. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
Spencer JM; Tannenbaum A; Sloan L; Amonette RA
Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of basal cell carcinoma biopsies with negative margins: A retrospective cohort study.
Willardson HB; Lombardo J; Raines M; Nguyen T; Park J; Dalton S; Ritchie S
J Am Acad Dermatol; 2018 Jul; 79(1):42-46. PubMed ID: 29307646
[TBL] [Abstract][Full Text] [Related]
14. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
15. Favourable results of Mohs micrographic surgery for basal cell carcinoma.
Gniadecki R; Glud M; Mortensen K; Bang B; Biskup E; Omland SH
Dan Med J; 2015 Dec; 62(12):A5171. PubMed ID: 26621396
[TBL] [Abstract][Full Text] [Related]
16. Is curettage really necessary for basal cell carcinoma before Mohs micrographic surgery?
Kimyai-Asadi A; Jih MH; Goldberg LH
Dermatol Surg; 2004 May; 30(5):820; author reply 821-2. PubMed ID: 15099334
[No Abstract] [Full Text] [Related]
17. Surgical treatment of basal cell carcinoma and squamous cell carcinoma.
Gualdi G; Monari P; Apalla Z; Lallas A
G Ital Dermatol Venereol; 2015 Aug; 150(4):435-47. PubMed ID: 26140396
[TBL] [Abstract][Full Text] [Related]
18. A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma.
Venturini M; Gualdi G; Zanca A; Lorenzi L; Pellacani G; Calzavara-Pinton PG
Br J Dermatol; 2016 Feb; 174(2):380-5. PubMed ID: 26498991
[TBL] [Abstract][Full Text] [Related]
19. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery.
Huang CC; Boyce S; Northington M; Desmond R; Soong SJ
J Am Acad Dermatol; 2004 Oct; 51(4):585-91. PubMed ID: 15389195
[TBL] [Abstract][Full Text] [Related]
20. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
